Literature DB >> 23619297

Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells.

Taiki Kida1, Yoshiki Tsubosaka, Masatoshi Hori, Hiroshi Ozaki, Takahisa Murata.   

Abstract

OBJECTIVE: TGR5 is a G-protein-coupled receptor for bile acids. So far, little is known about the function of TGR5 in vascular endothelial cells. APPROACH AND
RESULTS: In bovine aortic endothelial cells, treatment with a bile acid having a high affinity to TGR5, taurolithocholic acid (TLCA), significantly increased NO production. This effect was abolished by small interfering RNA-mediated depletion of TGR5. TLCA-induced NO production was also observed in human umbilical vein endothelial cells measured via intracellular cGMP accumulation. TLCA increased endothelial NO synthase(ser1177) phosphorylation in human umbilical vein endothelial cells. This response was accompanied by increased Akt(ser473) phosphorylation and intracellular Ca(2+). Inhibition of these signals significantly decreased TLCA-induced NO production. We next examined whether TGR5-mediated NO production affects inflammatory responses of endothelial cells. In human umbilical vein endothelial cells, TLCA significantly reduced tumor necrosis factor-α-induced adhesion of monocytes, vascular cell adhesion molecule-1 expression, and activation of nuclear factor-κB. TLCA also inhibited lipopolysaccharide-induced monocyte adhesion to mesenteric venules in vivo. These inhibitory effects of TLCA were abrogated by NO synthase inhibition.
CONCLUSIONS: TGR5 agonism induces NO production via Akt activation and intracellular Ca(2+) increase in vascular endothelial cells, and this function inhibits monocyte adhesion in response to inflammatory stimuli.

Entities:  

Keywords:  Akt; TGR5; endothelial NO synthase; inflammation; intracellular Ca2+

Mesh:

Substances:

Year:  2013        PMID: 23619297     DOI: 10.1161/ATVBAHA.113.301565

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  35 in total

Review 1.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

Review 2.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

Review 3.  Bile Acid Metabolism in Liver Pathobiology.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Gene Expr       Date:  2018-01-11

4.  Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice.

Authors:  Prasant Kumar Jena; Lili Sheng; Kyle Mcneil; Thinh Q Chau; Sebastian Yu; Maija Kiuru; Maxwell A Fung; Samuel T Hwang; Yu-Jui Yvonne Wan
Journal:  J Dermatol Sci       Date:  2019-06-08       Impact factor: 4.563

5.  TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.

Authors:  Zeena Eblimit; Sundararajah Thevananther; Saul J Karpen; Heinrich Taegtmeyer; David D Moore; Luciano Adorini; Daniel J Penny; Moreshwar S Desai
Journal:  Cardiovasc Ther       Date:  2018-08-22       Impact factor: 3.023

6.  Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation.

Authors:  Pavan Bhargava; Matthew D Smith; Leah Mische; Emily Harrington; Kathryn C Fitzgerald; Kyle Martin; Sol Kim; Arthur Anthony Reyes; Jaime Gonzalez-Cardona; Christina Volsko; Ajai Tripathi; Sonal Singh; Kesava Varanasi; Hannah-Noelle Lord; Keya Meyers; Michelle Taylor; Marjan Gharagozloo; Elias S Sotirchos; Bardia Nourbakhsh; Ranjan Dutta; Ellen M Mowry; Emmanuelle Waubant; Peter A Calabresi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

7.  Bile acid metabolism and signaling in liver disease and therapy.

Authors:  John Y L Chiang
Journal:  Liver Res       Date:  2017-05-10

Review 8.  Bile acid signaling in metabolic disease and drug therapy.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

9.  Restructuring the Gut Microbiota by Intermittent Fasting Lowers Blood Pressure.

Authors:  Huanan Shi; Bojun Zhang; Taylor Abo-Hamzy; James W Nelson; Chandra Shekar R Ambati; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Circ Res       Date:  2021-02-18       Impact factor: 17.367

10.  Microbiome and Cardiovascular Disease.

Authors:  Hilde Herrema; Max Nieuwdorp; Albert K Groen
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.